RARS1 and neoplasm: Western blot analysis showed that RARS1 knockdown reduced PI3K and phosphorylat-AKT(p-AKT) levels, while increasing GSK3β expression, suggesting that RARS1 modulates the PI3K/p-AKT/GSK3β signaling pathway in tumor proliferation and migration (Figure 5C).